Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and 2C-T-4: Difference between pages
Appearance
(Difference between pages)
Content deleted Content added
Saving copy of the {{chembox}} taken from revid 467128279 of page 2C-T-4 for the Chem/Drugbox validation project (updated: 'CASNo'). |
No edit summary |
||
Line 1: | Line 1: | ||
{{more citations needed|date=November 2013}} |
|||
{{ambox | text = This page contains a copy of the infobox ({{tl|chembox}}) taken from revid [{{fullurl:2C-T-4|oldid=467128279}} 467128279] of page [[2C-T-4]] with values updated to verified values.}} |
|||
{{chembox |
{{chembox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| ImageSize1 = 200px |
| ImageSize1 = 200px |
||
| ImageFile2 = 2C-T-4-3d-sticks.png |
| ImageFile2 = 2C-T-4-3d-sticks.png |
||
| ImageSize2 = 200px |
| ImageSize2 = 200px |
||
| PIN = 2-<nowiki/>{2,5-Dimethoxy-4-[(propan-2-yl)sulfanyl]phenyl}ethan-1-amine |
|||
| IUPACName = 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine |
|||
| OtherNames = |
| OtherNames = |
||
| Section1 = {{Chembox Identifiers |
| Section1 = {{Chembox Identifiers |
||
Line 15: | Line 17: | ||
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
| ChEMBL_Ref = {{ebicite|correct|EBI}} |
||
| ChEMBL = 338259 |
| ChEMBL = 338259 |
||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
| KEGG = C22735 |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C13H21NO2S/c1-9(2)17-13-8-11(15-3)10(5-6-14)7-12(13)16-4/h7-9H,5-6,14H2,1-4H3 |
| StdInChI = 1S/C13H21NO2S/c1-9(2)17-13-8-11(15-3)10(5-6-14)7-12(13)16-4/h7-9H,5-6,14H2,1-4H3 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = HDYZSVKZKDPLDT-UHFFFAOYSA-N |
| StdInChIKey = HDYZSVKZKDPLDT-UHFFFAOYSA-N |
||
| CASNo_Ref = {{cascite|correct| |
| CASNo_Ref = {{cascite|correct|chemspider}} |
||
| CASNo = |
| CASNo = 207740-25-8 |
||
| UNII_Ref = {{fdacite|changed|FDA}} |
|||
⚫ | |||
| UNII = 558WSD71D4 |
|||
⚫ | |||
| SMILES = CC(C)Sc1cc(OC)c(cc1OC)CCN |
| SMILES = CC(C)Sc1cc(OC)c(cc1OC)CCN |
||
}} |
}} |
||
| Section2 = {{Chembox Properties |
| Section2 = {{Chembox Properties |
||
| C=13 |
|||
| Formula = C<sub>13</sub>H<sub>21</sub>NO<sub>2</sub>S |
|||
| H=21 |
|||
| MolarMass = 255.38 g/mol |
|||
| N=1 |
|||
| O=2 |
|||
| S=1 |
|||
| Appearance = |
| Appearance = |
||
| Density = |
| Density = |
||
Line 35: | Line 44: | ||
| MainHazards = |
| MainHazards = |
||
| FlashPt = |
| FlashPt = |
||
| |
| AutoignitionPt = }} |
||
}} |
}} |
||
'''2C-T-4''' ('''2,5-dimethoxy-4-isopropylthiophenethylamine''') is a [[psychedelic drug|psychedelic]] [[phenethylamine]] of the [[2C (psychedelics)|2C family]]. It was first synthesized by [[Alexander Shulgin]] and is used as [[entheogen]]ic [[recreational drug]]. |
|||
==Chemistry== |
|||
2C-T-4 is the [[2C (psychedelics)|2-carbon]] [[homologous series|homolog]] of [[Aleph (psychedelic)|aleph-4]]. The full chemical name is 2-[4-([[isopropyl]][[Thio-|thio]])-2,5-di[[methoxy]][[phenyl]]]-[[ethyl group|ethan]][[amine]]. The drug has [[structure|structural]] and [[pharmacodynamic]] properties similar to [[2C-T-7]] and [[2C-T-19]].{{citation needed|date=March 2015}} |
|||
==Effects== |
|||
2C-T-4 produces psychedelic and entheogenic effects that develop slowly and can last 8–16 hours.{{medcn|date=March 2015}} While users may experience virtually no effects for the first hour after ingestion, results vary drastically between individuals and range from [[hallucination]] and [[euphoria]] to intense sickness and anxiety.<ref name="CitePiHKAL">{{CitePiHKAL}}</ref> Shulgin devoted a chapter in the first part of his book ''[[PiHKAL]]'' to this compound, describing an intense [[Shulgin Rating Scale|"plus-four"]] psychedelic experience mediated by a twelve milligram dose. |
|||
==Pharmacology== |
|||
{{OR section|date=March 2015}} |
|||
The mechanism that produces 2C-T-4's hallucinogenic and entheogenic effects has not been specifically established, however it is most likely to result from action as a [[5-HT2A receptor|5-HT<sub>2A</sub>]] [[5-HT receptor|serotonin receptor]] [[agonist]] in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known. |
|||
==Popularity== |
|||
2C-T-4 is relatively unknown on the black market, but has been sold to a limited extent on the [[research chemical]] market. |
|||
==Drug prohibition laws== |
|||
===Canada=== |
|||
As of October 31, 2016, 2C-T-4 is a controlled substance (Schedule III) in Canada.<ref>{{Cite web|url=http://gazette.gc.ca/rp-pr/p2/2016/2016-05-04/html/sor-dors72-eng.php|title=Canada Gazette – Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)|date=4 May 2016}}</ref> |
|||
===China=== |
|||
As of October 2015 2C-T-4 is a controlled substance in China.<ref>{{cite web | url=http://www.sfda.gov.cn/WS01/CL0056/130753.html | title=关于印发《非药用类麻醉药品和精神药品列管办法》的通知 | publisher=China Food and Drug Administration | date=27 September 2015 | language=zh | access-date=1 October 2015 | archive-url=https://web.archive.org/web/20151001222554/http://www.sfda.gov.cn/WS01/CL0056/130753.html | archive-date=1 October 2015 | url-status=dead }}</ref> |
|||
===Denmark=== |
|||
2C-T-4 is added to the list of Schedule B controlled substances.<ref>{{cite web |url=https://www.retsinformation.dk/Forms/R0710.aspx?id=137169 |title = Retsinformation}}</ref> |
|||
===Sweden=== |
|||
[[Riksdag|''Sveriges riksdags'']] health ministry [[:sv:Statens folkhälsoinstitut|''Statens folkhälsoinstitut'']] classified 2C-T-4 as "health hazard" under the act [[:sv:Lagen om förbud mot vissa hälsofarliga varor|''Lagen om förbud mot vissa hälsofarliga varor'']] (translated ''Act on the Prohibition of Certain Goods Dangerous to Health'') as of Jul 15, 2007, in their regulation '''SFS 2007:600''' listed as '''2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)''', making it illegal to sell or possess.<ref>{{cite web |last=Larsson |first=Maria |url=http://www.notisum.se/rnp/sls/sfs/20070600.pdf |title=Svensk författningssamling |access-date=January 24, 2022}}</ref> |
|||
===United States=== |
|||
As of July 9, 2012, 2C-T-4 is a Schedule I substance in the United States, under the Synthetic Drug Abuse Prevention Act of 2012.<ref>{{cite web|last=Portman|title=Synthetic Drug Abuse Prevention Act of 2012|url=http://www.govtrack.us/congress/bills/112/s3190/text|publisher=Govtrack|access-date=22 July 2012}}</ref> |
|||
==Homologue== |
|||
[[Image:Psi-2C-T-4.png|thumb|200px|right|Ψ-2C-T-4, the homologue of 2C-T-4]] |
|||
2C-T-4 has one homologue, the structural isomer Ψ-2C-T-4 (2,6-dimethoxy-4-(i)-propylthiophenethylamine). This compound was tested by [[Alexander Shulgin]] at a dose of 12 mg. |
|||
At this dosage its duration was very short and it produced few effects, however based on the research into the better characterized compound [[Psi-DOM|Ψ-DOM]], the potency of Ψ-2C-T-4 is likely to be around 1/3 that of 2C-T-4 itself, so a more effective dosage of Ψ-2C-T-4 might be in the region of 20–60 mg;<ref name="CitePiHKAL"/> however high doses such as this might well be associated with toxic side effects, and so extreme caution would be advised. |
|||
==References== |
|||
{{reflist}} |
|||
==External links== |
|||
*[http://www.erowid.org/library/books_online/pihkal/pihkal041.shtml PiHKAL #41 2C-T-4] |
|||
* [http://pihkal.info/read.php?domain=pk&id=41 2C-T-4 Entry in PiHKAL • info] |
|||
* [http://pihkal.info/read.php?domain=pk&id=42 Ψ-2C-T-4 Entry in PiHKAL • info] |
|||
{{2C's}} |
|||
{{Hallucinogenic phenethylamines}} |
|||
[[Category:2C (psychedelics)]] |
|||
[[Category:Thioethers]] |
|||
[[Category:Designer drugs]] |
|||
[[Category:Isopropyl compounds]] |